Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
KD Alert: Securities Fraud Lawsuit Filed – Act by April 13! Dividend Policy & Yield No Dividend History: Since its spinoff from IBM in late 2021, Kyndryl Holdings (NYSE: KD) has…
Read more# NOC: Libya's Oil Licensing Round Fizzles—What’s Next? **Company & Context:** *Northrop Grumman Corporation (NOC)* is a U.S. aerospace and defense contractor, not to be confused…
Read more# Discover Analysts’ Insights on REGN’s Next Move!
Read more# GE: Unlock Insights from Global Clinical Trials Review 2025 ## Dividend Policy & History General Electric’s dividend has seen a dramatic shift over the past decade.
Read more# KD: 55% Drop Sparks Class Action—What You Need to Know! ## Introduction: What Happened to Kyndryl (KD)? Kyndryl Holdings, Inc.
Read more# ICLR Alert: Contact Kirby McInerney on Potential Violations! **Overview:** Icon Public Limited Company (NASDAQ: **ICLR**), a global contract research organization (CRO), is…
Read more# CWST: Q4 FY2025 Results & FY2026 Guidance Just Dropped! ## Q4 FY2025 Results Highlights & FY2026 Outlook Casella Waste Systems (NASDAQ: **CWST**), a regional solid waste and…
Read more# EIC: €2.5M Grant Fuels Breakthrough in Tumor Treatment! ## Company Overview & EIC-Funded Breakthrough Elicera Therapeutics AB (publ) – listed on Nasdaq First North in Stockholm…
Read more# TLX: Unlocking Growth with FY 2025 Results! ## Company Overview Telix Pharmaceuticals Limited (TLX) is a radiopharmaceutical company specializing in diagnostic and therapeutic…
Read more# MREO Investors: Act Now Before Class Action Deadline!
Read more# Citigroup: Geron Inducement Grants Spark Market Buzz! **Introduction:** Recent headlines show how even niche corporate actions can capture market attention.
Read more# Join the VTGN Class Action by March 16—Don’t Miss Out!
Read more# MRK: Keytruda Sales Surge—Unlocking New Growth Potential! **Merck & Co. (NYSE: MRK)** is riding a wave of growth driven by its blockbuster cancer immunotherapy *Keytruda*.
Read more# MRNA: Quack Backtracks on FDA mRNA Vax Attack! **On behalf of:** *Unknown Publisher* ## Company Overview and Recent Developments Moderna, Inc. (NASDAQ: MRNA) rose to prominence…
Read more# AGI: Alamos Gold’s Q4 & Year-End 2025 Results Unveiled! ## Q4 & FY2025 Performance Highlights Alamos Gold reported strong financial results for the fourth quarter and full-year…
Read more# GERN’s New Inducement Grants: What You Need to Know!
Read more# HCC: Breakthrough in Hepatocellular Carcinoma Treatment! ## Company Overview **Warrior Met Coal, Inc.
Read more# BMRA: Vietnam Greenlights Biomerica's EZ Detect™! ## Vietnam Approval & Company Overview Biomerica, Inc. (NASDAQ: BMRA) is a small-cap provider of diagnostic solutions focused…
Read more# MREO: Class Action Filed—Investors Urged to Act Now!
Read more# CDE: Year-End 2025 Reserves Report Sparks Investor Interest! **Coeur Mining, Inc. (NYSE: CDE)** – a U.S.-based gold and silver miner – delivered a bullish year-end 2025 mineral…
Read more
